Skip to content

Protease inhibitors and heart disease - more evidence of risk

The positives and negatives of involving people with HIV in NGOs

Apparent benefit from treatment interruption before multi-drug salvage therapy

Late diagnosis of UK nationals at low risk of HIV

No decline in HIV testing in Scotland following Stephen Kelly case

Private sector ARV schemes in Africa report progress

Further data on pegylated interferon in HCV/HIV coinfection

NRTI-sparing regimen achieves better viral suppression

Switch to atazanavir associated with cholesterol and triglyceride reductions

Scaling up antiretroviral therapy: lessons from Brazil

Why $10 billion for AIDS?

Merck unveils integrase inhibitor

Antiretroviral access: experience from Haiti

Nutrition, the neglected side of AIDS care in developing countries

Fusion inhibitor provides superior salvage

Growth hormone reduces fat accumulation

ACTG 384: Major HAART strategy trial a closing day highlight in Barcelona

International AIDS Society chief signals aggressive commitment to treatment access